Author:
Demotes-Mainard Jacques,Canet Emmanuel,Segard Lionel,Allain H.,Amédée-Manesme O.,Aymé S.,Boubekeur K.,Chabrier P.-E.,Clément B.,Collet J.-P.,Deregnaucourt J.,Habert Ortoli E.,Halioua E.,Hamelin B.,Juillet Y.,Lacombe D.,Lassale C.,Longuet M.,Pletan Y.,Vasmant D.,Vincent C.
Reference25 articles.
1. Innovation or Stagnation? Challenge and Opportunity on the Critical Path to New Medical Products. www.fda.gov/oc/initiatives/criticalpath/whitepaper.html
2. The NIH Roadmap;Zerhouni;Science,2003
3. Translational and clinical science - time for a new vision;Zerhouni;NEJM,2005
4. The Europen rare disease thertapeutic initiative. A PPP is promoting research on new treatments for rare diseases;Fischer;PLoS Medicine,2005
5. PPPs succeeding in tackling neglected diseases;Frantz;Nature Rev Drug Discov,2005
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献